[Corrigendum] DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
- Authors:
- Published online on: January 9, 2020 https://doi.org/10.3892/ol.2020.11285
- Pages: 2072-2072
-
Copyright : © Yong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
Oncol Lett 14: [Related article:] 8171-8177, 2017; DOI: 10.3892/ol.2017.7184
Subsequently to the publication of the above article, the authors have realized that Figs. 1 and 2 contained incorrect GAPDH control bands; in particular, the same GADPH bands had erroneously been included twice in Fig. 2 for experiments that involved two different cell lines. These GAPDH bands were included inadertently in this pair of figures owing to a mislabelling of the original data files.
The corrected versions of Figs. 1 and 2, as they should have appeared in the Journal, are shown opposite. All the authors agree to this Corrigendum. Note that the revisions made to these figures do not adversely affect the results reported in the paper, or the conclusions stated therein. The authors regret that these errors were not noticed prior to the publication of this article, and offer their apologies to the Editor and to the readers of the Journal.